Eslam Mohamed

1.9k total citations
34 papers, 1.2k citations indexed

About

Eslam Mohamed is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Eslam Mohamed has authored 34 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Immunology, 11 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in Eslam Mohamed's work include interferon and immune responses (6 papers), Immune Cell Function and Interaction (6 papers) and Immune cells in cancer (5 papers). Eslam Mohamed is often cited by papers focused on interferon and immune responses (6 papers), Immune Cell Function and Interaction (6 papers) and Immune cells in cancer (5 papers). Eslam Mohamed collaborates with scholars based in United States, Egypt and Georgia. Eslam Mohamed's co-authors include Paulo C. Rodrı́guez, David H. Munn, Lei Huang, Andrew L. Mellor, Henrique Lemos, Gabriela Pacholczyk, Rong Ou, Ali S. Arbab, Juan R. Cubillos‐Ruiz and Jimena Trillo-Tinoco and has published in prestigious journals such as Nature Communications, Immunity and The Journal of Immunology.

In The Last Decade

Eslam Mohamed

31 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eslam Mohamed United States 15 699 435 291 139 123 34 1.2k
Nicholas J. Bessman United States 12 444 0.6× 575 1.3× 235 0.8× 159 1.1× 56 0.5× 14 1.2k
Ivan Peng United States 12 535 0.8× 444 1.0× 130 0.4× 86 0.6× 50 0.4× 12 1.2k
Sarah H. Ross United Kingdom 11 517 0.7× 459 1.1× 254 0.9× 77 0.6× 47 0.4× 15 1.1k
Nadia Luheshi United Kingdom 13 547 0.8× 536 1.2× 270 0.9× 28 0.2× 30 0.2× 35 1.1k
Ryan Sowell United States 9 979 1.4× 507 1.2× 394 1.4× 23 0.2× 40 0.3× 14 1.4k
Oihana Murillo Spain 18 642 0.9× 313 0.7× 544 1.9× 38 0.3× 33 0.3× 26 1.2k
Katherine H. Parker United States 11 888 1.3× 361 0.8× 492 1.7× 34 0.2× 16 0.1× 14 1.4k
Neelakshi R. Jog United States 15 375 0.5× 351 0.8× 167 0.6× 65 0.5× 56 0.5× 22 931
David Saliba United Kingdom 14 562 0.8× 375 0.9× 171 0.6× 36 0.3× 22 0.2× 19 970
Emilio Boada-Romero United States 11 659 0.9× 499 1.1× 81 0.3× 133 1.0× 54 0.4× 14 1.4k

Countries citing papers authored by Eslam Mohamed

Since Specialization
Citations

This map shows the geographic impact of Eslam Mohamed's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eslam Mohamed with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eslam Mohamed more than expected).

Fields of papers citing papers by Eslam Mohamed

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eslam Mohamed. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eslam Mohamed. The network helps show where Eslam Mohamed may publish in the future.

Co-authorship network of co-authors of Eslam Mohamed

This figure shows the co-authorship network connecting the top 25 collaborators of Eslam Mohamed. A scholar is included among the top collaborators of Eslam Mohamed based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eslam Mohamed. Eslam Mohamed is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Mohamed, Eslam, et al.. (2025). Genomic analysis and replication kinetics of the closely related EHV-1 neuropathogenic 21P40 and abortigenic 97P70 strains. Veterinary Research. 56(1). 12–12. 1 indexed citations
4.
Yang, Catherine, et al.. (2025). Immunotherapeutic Approaches to Peanut Allergy Treatment—Pre-Clinical and Clinical Studies: A Comprehensive Review. Journal of Clinical Medicine. 14(6). 1902–1902. 1 indexed citations
5.
Osman, Mohamed, et al.. (2024). Exploring Bioactive Potential of Streptomyces thinghirensis WAE1 from Wadi El-Natron, Egypt. Indian Journal of Microbiology. 64(4). 1685–1696. 3 indexed citations
8.
Osman, Mohamed, et al.. (2024). Therapeutic potential activity of quercetin complexes against Streptococcus pneumoniae. Scientific Reports. 14(1). 12876–12876. 3 indexed citations
9.
Mandula, Jay K., Darwin Chang, Rachel Jimenez, et al.. (2022). 944 Targeting of notch ligand Jagged2 in lung cancer cells drives anti-tumor immunity via notch-induced functional reprogramming of tumor-associated macrophages. Regular and Young Investigator Award Abstracts. A986–A986.
10.
Chen, Zhihua, Jiannong Li, Eslam Mohamed, et al.. (2021). Targeted Therapy Given after Anti–PD-1 Leads to Prolonged Responses in Mouse Melanoma Models through Sustained Antitumor Immunity. Cancer Immunology Research. 9(5). 554–567. 19 indexed citations
11.
Cao, Yu, Jimena Trillo-Tinoco, Rosa A. Sierra, et al.. (2019). ER stress-induced mediator C/EBP homologous protein thwarts effector T cell activity in tumors through T-bet repression. Nature Communications. 10(1). 1280–1280. 111 indexed citations
12.
Trillo-Tinoco, Jimena, Rosa A. Sierra, Eslam Mohamed, et al.. (2019). AMPK Alpha-1 Intrinsically Regulates the Function and Differentiation of Tumor Myeloid-Derived Suppressor Cells. Cancer Research. 79(19). 5034–5047. 39 indexed citations
13.
Cao, Yu, Eslam Mohamed, Jimena Trillo-Tinoco, et al.. (2019). Polyphenol-rich extract induces apoptosis with immunogenic markers in melanoma cells through the ER stress-associated kinase PERK. Cell Death Discovery. 5(1). 134–134. 43 indexed citations
14.
Cao, Yu, Jimena Trillo-Tinoco, Rosa A. Sierra, et al.. (2019). Publisher Correction: ER stress-induced mediator C/EBP homologous protein thwarts effector T cell activity in tumors through T-bet repression. Nature Communications. 10(1). 3680–3680. 5 indexed citations
15.
Palani, Chithra D., Abdelrahman Y. Fouda, Fang Liu, et al.. (2019). Deletion of Arginase 2 Ameliorates Retinal Neurodegeneration in a Mouse Model of Multiple Sclerosis. Molecular Neurobiology. 56(12). 8589–8602. 16 indexed citations
16.
Sierra, Rosa A., Jimena Trillo-Tinoco, Eslam Mohamed, et al.. (2017). Anti-Jagged Immunotherapy Inhibits MDSCs and Overcomes Tumor-Induced Tolerance. Cancer Research. 77(20). 5628–5638. 60 indexed citations
17.
Cubillos‐Ruiz, Juan R., Eslam Mohamed, & Paulo C. Rodrı́guez. (2017). Unfolding anti-tumor immunity: ER stress responses sculpt tolerogenic myeloid cells in cancer. Journal for ImmunoTherapy of Cancer. 5(1). 5–5. 80 indexed citations
18.
Mohamed, Eslam, Yu Cao, & Paulo C. Rodrı́guez. (2017). Endoplasmic reticulum stress regulates tumor growth and anti-tumor immunity: a promising opportunity for cancer immunotherapy. Cancer Immunology Immunotherapy. 66(8). 1069–1078. 82 indexed citations
19.
Lemos, Henrique, Eslam Mohamed, Lei Huang, et al.. (2016). STING Promotes the Growth of Tumors Characterized by Low Antigenicity via IDO Activation. Cancer Research. 76(8). 2076–2081. 251 indexed citations
20.
Huang, Lei, Rong Ou, Guilherme R. Souza, et al.. (2016). Virus Infections Incite Pain Hypersensitivity by Inducing Indoleamine 2,3 Dioxygenase. PLoS Pathogens. 12(5). e1005615–e1005615. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026